31 Jul 2026
Evaluation of quinoxaline-2-one-hydrazone hybrid as VEGFR-2 inhibitors and apoptosis inducers: Design, synthesis, anticancer assessment, and in silico studyPublisher siteJournal of Molecular Structure, Angiogenesis and VEGF in Cancer
Active, last published 2026
In synthesis and biological activity
Alaa
Elwan
Scholar“Research focused on Synthesis and biological activity and adjacent fields.”
Al-Azhar University
Egypt
Claim Your ProfileEgypt21
H-index
1.3k
Citations
Alaa has not officially claimed their profile. If you are Alaa, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
laa Elwan is a researcher working on Synthesis and biological activity. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Alaa's work has been cited 1,250 times across 5 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Synthesis and biological activity×24Angiogenesis and VEGF in Cancer×17Bioactive Compounds and Antitumor Agents×13Synthesis and Biological Evaluation×12PI3K/AKT/mTOR signaling in cancer×6
04 · Where I am
Affiliations
Affiliation on published researchAl-Azhar University, EgyptDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
11 works25 Apr 2026
Quinoxaline-based scaffolds as dual VEGFR-2/EGFR kinase inhibitors and apoptotic inducers: Design, synthesis, anticancer evaluation, and in silico studyPublisher siteBioorganic Chemistry, Synthesis and Biological Evaluation
3 Dec 2025
Identification of Benzenesulfonamide-Containing Thiazolidine-2,4-Dione Derivatives as Novel Carbonic Anhydrase II and VII Inhibitors with Anti-Epileptic ActivityPublisher siteJournal of Medicinal Chemistry
18 Nov 20251cites
2,3-Dihydro-1,3,4-thiadiazoles as dual B-Raf / VEGFR-2 inhibitors: Design, synthesis, and anti-breast cancer assessmentPublisher siteJournal of Molecular Structure
22 Mar 202414cites
New thiazolidine-2,4-diones as potential anticancer agents and apoptotic inducers targeting VEGFR-2 kinase: Design, synthesis, in silico and in vitro studiesPublisher siteBiochimica et Biophysica Acta (BBA) - General Subjects, Cancer Mechanisms and Therapy
15 Mar 20245cites
Novel Thiazolidine‐2,4‐Dione Derivatives as Potential VEGFR‐2 Inhibitors: Synthesis, Biological Testing, and <i>in Silico</i> StudiesPublisher siteChemistrySelect, Angiogenesis and VEGF in Cancer
1 Jan 2024Open access8cites
Discovery of new thiazolidine-2,4-dione derivatives as potential VEGFR-2 inhibitors: In vitro and in silico studiesPublisher siteHeliyon, Synthesis and biological activity
15 Dec 2023Open access12cites
New nicotinamide derivatives as potential anticancer agents targeting VEGFR-2: design, synthesis, <i>in vitro</i> , and <i>in silico</i> studiesPublisher siteJournal of Biomolecular Structure and Dynamics, Cancer Mechanisms and Therapy
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Alaa?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you